Follow the SeqLL, Inc. share price and the full management transaction log of the company, a listed issuer based in United States. Shares are listed on the US market, under the supervision of SEC (Form 4). Market capitalisation: €2.2bn. The latest transaction was filed on 30 January 2023 (Acquisition). Among the most active insiders: JONES DANIEL ROBERT. All data is accessible without an account.
15
Insider Decl.
n/a
Thresholds
€28,418
15 ops.
Buy Volume
n/a
n/a
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate SeqLL, Inc. Strong Buy (bullish), based on 12 analysts. Average price target: US$59.30.
52Σ signal
Buys €28,418n/a Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 27,675 of 29,052 companies
15.5
score / 100
Value
23
Quality
9
FCF yld-4.0%
Earn yld-5.1%
EV/EBITDA·
ROE-40%
Gross mgn11%
Net mgn-30%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
1 shares@ US$0.980.0% of flowCommon StockSEC:0001213900-22-049619:0
Canonical exit: 15 Nov 2022 (T+90)
15 of 15 declarations
About SeqLL, Inc.
SeqLL, Inc. is a company focused on developing DNA sequencing technologies. It aims to enhance sequencing methods for applications in research and diagnostics.